0

BI-9564

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP1883429228
CAS1883429-22-8
Molecular Weight353.41
InChI KeyBJFSUDWKXGMUKA-UHFFFAOYSA-N
Description≥97% (HPLC)
SolubilityDMSO: 2 mg/mL, clear (warmed)
Assay≥97% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditions2-8°C
1

An Advanced Tool To Interrogate BRD9

Rezaul M Karim, Ernst Schönbrunn

J Med Chem. 2016 May 26;59(10):4459-61.

PMID: 27120693

1

BRD9 Inhibition, Alone or in Combination With Cytostatic Compounds as a Therapeutic Approach in Rhabdoid Tumors

Katja F Krämer, Natalia Moreno, Michael C Frühwald, Kornelius Kerl

Int J Mol Sci. 2017 Jul 16;18(7):1537.

PMID: 28714904

1

Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor

Laetitia J Martin, Manfred Koegl, Gerd Bader, Xiao-Ling Cockcroft, Oleg Fedorov, Dennis Fiegen, Thomas Gerstberger, Marco H Hofmann, Anja F Hohmann, Dirk Kessler, Stefan Knapp, Petr Knesl, Stefan Kornigg, etc.

J Med Chem. 2016 May 26;59(10):4462-75.

PMID: 26914985

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode